Found 11 results

2009
ADVANCE Collaborative Group, Writing Committee, Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M, Patel A, Cass A et al..  2009.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 20:1813-21.[IF7.111]..
ADVANCE Collaborative Group, Writing Committee, Kengne A-P , Czernichow S , Huxley R , Grobbee D, Woodward M, Neal B, Zoungas S, Cooper M et al..  2009.  Blood pressure variables and cardiovascular risk: New findings from ADVANCE.. Hypertension. 54:399-404.[IF7.368]..
ADVANCE Collaborative Group, de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M et al..  2009.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in people with type 2 diabetes; the ADVANCE trial. Diabetelogia. 52:2329-36.[IF6.418].
White S, Perkovic V, Cass A, Chang C, Poulter N, Spector T, Haysom L, Craig J, Al Salmi I, Chadban S et al..  2009.  Is low birth weight an antecedent of chronic kidney disease in later life? A systematic review of observational studies American Journal of Kidney Diseases . :[Epubaheadofprint].[IF3.981].
ADVANCE Collaborative Group, Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S et al..  2009.  Risk of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and artrial fibrillation . results of the ADVANCE study. Eur Heart J. 30 :1128-35.[IF7.924]..
ADVANCE Collaborative Group, de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S et al..  2009.  Routine blood pressure lowering and kidney disease in type 2 diabetes. J Am Soc Nephrol. 20:883-92.[IF7.111].
2008
ADVANCE Collaborative Group Writing Group, (Writing Committee), Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M et al..  2008.  Intensive blood glucose control on vascular outcomes in patients with type 2 diabetes . N Engl J Med . 358:2560-72.[IF52.589][Grant:ADVANCE&ProgramGrant].
Chalmers J, [Booklet contributing authors], MacMahon S, Neal B, Patel A, Perkovic V, Kengne AP, Colagiuri S, Grobbee R, Hamet P et al..  2008.  New approaches for the prevention of vascular disease in Type 2 diabetes. :271-95.
Chalmers J, [Contributing authors], Colagiuri S, Cooper M, Grobbee R, Hamet P, Kengne A-P, MacMahon S, Marre M, Mogensen C-E et al..  2008.  Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III.
Chalmers J, contributing authors, Colagiuri S, Cooper M, Grobbee R, Hamet P, Kengne AP, MacMahon S, Marre M, Mogensen CE et al..  2008.  Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR. Issue III.
2007
Patel A, ADVANCE Collaborative Group, (Writing Committee), MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N et al..  2007.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet . 370:829-40.[IF28.638].

Latest news

Recently added pages

Our focus

George Institute sites